[SLRX] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
06-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 23.84%
YoY- 74.98%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 875 165 105 163 251 246 179 187.75%
PBT -2,630 -1,385 -2,230 -2,009 -2,638 -9,052 -8,223 -53.19%
Tax -2 0 0 -51 0 0 0 -
NP -2,628 -1,385 -2,230 -2,009 -2,638 -9,052 -8,223 -53.22%
Tax Rate - - - - - - - -
Total Cost 3,503 1,549 2,335 2,172 2,889 9,297 8,402 -44.16%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -300.33 -840.76 -2,124.68 -1,232.52 -1,051.18 -3,687.09 -4,604.73 -83.77%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -18.22 -11.48 -77.16 -69.50 -91.27 -313.66 -287.22 -84.06%
EPS Diluted -18.22 -11.48 -77.16 -69.50 -91.27 -313.66 -287.22 -84.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.